Statins and muscles: What price glory?

Joint Bone Spine

Volumn 69, Issue 3, 2002, Pages 249-251

  Hayem, Gilles ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Muscle; Rhabdomyolysis; Side effect; Statin

Indexed keywords

CHOLSTAT; CREATINE KINASE; CYCLOSPORIN; DILTIAZEM; FENOFIBRATE; GEMFIBROZIL; IMIDAZOLE DERIVATIVE; MACROLIDE; MEVINOLIN; NEFAZODONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STALTOR; STATIN; UBIQUINONE; UNCLASSIFIED DRUG; WARFARIN; CERIVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIDINE DERIVATIVE;

AGING; CREATINE KINASE BLOOD LEVEL; DRUG CHOICE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EDITORIAL; FRANCE; HUMAN; KIDNEY FAILURE; MUSCLE ATROPHY; RHABDOMYOLYSIS; RISK FACTOR; TREATMENT INDICATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; SKELETAL MUSCLE;

HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MUSCLE, SKELETAL; PYRIDINES; RHABDOMYOLYSIS;

EID: 0035991120     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(02)00389-5     Document Type: Editorial

References (27)

1. Rhabdomyolysis after taking atorvastatin with gemfibrozil
2. A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy - A case report
3. Rhabdomyolysis and renal failure associated with cerivastatin- gemfibrozil combination therapy
4. Rhabdomyolysis induced by simvastatin and ketoconazole treatment
5. Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin
6. Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone
7. Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin
8. Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole
9. Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine
10. Rhabdomyolysis and acute renal failure due to combination therapy with simvastatin and warfarin
11. Cerivastatin-induced rhabdomyolysis in a renal transplant on cyclosporin
12. Rhabdomyolysis associated with concurrent use of simvastatin and diltiazem
13. Simvastatin-induced rhabdomyolysis in a patient with chronic renal failure
14. Cerivastatin-induced rhabdomyolysis in a patient with diabetic nephropathy
15. Bayer decides to withdraw cholesterol-lowering drug
16. Subchronic toxicity of atorvastatin, a hydroxymethylglutaryl-coenzyme A reductase inhibitor, in beagle dogs
17. HMG-CoA reductase inhibitor-induced myopathy in the rat: Cyclosporine A intetaction and mechanism studies
18. Lovastatin decreases coenzyme Q levels in humans
19. Effect of a long-term treatment with lovastatin or fenofibrate on hepatic and cardiac ubiquinone levels in cardiomyopathic hamster
20. Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans
21. The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle
22. HMG CoA reductase inhibitor-induced myotoxicity: Pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture
23. Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death
24. Inhibition of cholesterol biosynthesis by squalene epoxidase inhibitor avoids apoptotic cell death in L6 myoblasts
25. Tendons and fluoroquinolones. Unresolved issues